BROOKFIELD CORP (BN) Fundamental Analysis & Valuation

NYSE:BN • CA11271J1075

Current stock price

39.14 USD
+0.77 (+2.01%)
At close:
39.4 USD
+0.26 (+0.66%)
After Hours:

This BN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BN Profitability Analysis

1.1 Basic Checks

  • BN had positive earnings in the past year.
  • In the past year BN had a positive cash flow from operations.
  • Each year in the past 5 years BN has been profitable.
  • Of the past 5 years BN 4 years had a positive operating cash flow.
BN Yearly Net Income VS EBIT VS OCF VS FCFBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

1.2 Ratios

  • BN's Return On Assets of 0.16% is on the low side compared to the rest of the industry. BN is outperformed by 73.14% of its industry peers.
  • BN's Return On Equity of 1.78% is on the low side compared to the rest of the industry. BN is outperformed by 66.12% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.30%, BN is in line with its industry, outperforming 47.52% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BN is below the industry average of 7.15%.
Industry RankSector Rank
ROA 0.16%
ROE 1.78%
ROIC 3.3%
ROA(3y)0.17%
ROA(5y)0.38%
ROE(3y)1.84%
ROE(5y)3.62%
ROIC(3y)3.45%
ROIC(5y)3.35%
BN Yearly ROA, ROE, ROICBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • The Profit Margin of BN (1.12%) is worse than 71.90% of its industry peers.
  • In the last couple of years the Profit Margin of BN has declined.
  • BN has a Operating Margin (26.36%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of BN has grown nicely.
  • Looking at the Gross Margin, with a value of 37.81%, BN is in line with its industry, outperforming 40.08% of the companies in the same industry.
  • BN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 26.36%
PM (TTM) 1.12%
GM 37.81%
OM growth 3Y17.08%
OM growth 5Y10.73%
PM growth 3Y-9.6%
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-2.91%
BN Yearly Profit, Operating, Gross MarginsBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BN Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BN has more shares outstanding
  • The number of shares outstanding for BN has been increased compared to 5 years ago.
  • The debt/assets ratio for BN has been reduced compared to a year ago.
BN Yearly Shares OutstandingBN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BN Yearly Total Debt VS Total AssetsBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B

2.2 Solvency

  • BN has an Altman-Z score of 0.34. This is a bad value and indicates that BN is not financially healthy and even has some risk of bankruptcy.
  • BN has a worse Altman-Z score (0.34) than 64.88% of its industry peers.
  • BN has a Debt/Equity ratio of 4.62. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 4.62, BN is doing worse than 84.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACCN/A
BN Yearly LT Debt VS Equity VS FCFBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50B 100B 150B 200B 250B

2.3 Liquidity

  • BN has a Current Ratio of 0.58. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BN's Current ratio of 0.58 is on the low side compared to the rest of the industry. BN is outperformed by 71.49% of its industry peers.
  • A Quick Ratio of 0.49 indicates that BN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.49, BN is not doing good in the industry: 74.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.49
BN Yearly Current Assets VS Current LiabilitesBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BN Growth Analysis

3.1 Past

  • BN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.63%.
  • BN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.72% yearly.
  • The Revenue for BN has decreased by -12.68% in the past year. This is quite bad
  • BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)-17.63%
EPS 3Y-14.72%
EPS 5YN/A
EPS Q2Q%-53.96%
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y-6.8%
Revenue growth 5Y3.66%
Sales Q2Q%3.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.46% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 18.44% on average over the next years. This is quite good.
EPS Next Y39.04%
EPS Next 2Y32.32%
EPS Next 3Y30.46%
EPS Next 5YN/A
Revenue Next Year47.63%
Revenue Next 2Y30.64%
Revenue Next 3Y18.44%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN Yearly Revenue VS EstimatesBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
BN Yearly EPS VS EstimatesBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. BN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.95 indicates a rather expensive valuation of BN.
  • BN's Price/Earnings ratio is a bit more expensive when compared to the industry. BN is more expensive than 60.33% of the companies in the same industry.
  • BN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.96.
  • Based on the Price/Forward Earnings ratio of 12.91, the valuation of BN can be described as correct.
  • BN's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.04. BN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.95
Fwd PE 12.91
BN Price Earnings VS Forward Price EarningsBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BN is valued cheaply inside the industry as 82.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.33
BN Per share dataBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • BN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BN's earnings are expected to grow with 30.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y32.32%
EPS Next 3Y30.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. BN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.98%, BN is a good candidate for dividend investing.
  • BN's Dividend Yield is comparable with the industry average which is at 6.96.
  • BN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 5.98%

5.2 History

  • The dividend of BN decreases each year by -3.57%.
  • BN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BN has decreased its dividend recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN Yearly Dividends per shareBN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • 84.48% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP84.48%
EPS Next 2Y32.32%
EPS Next 3Y30.46%
BN Yearly Income VS Free CF VS DividendBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B
BN Dividend Payout.BN Dividend Payout, showing the Payout Ratio.BN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BN Fundamentals: All Metrics, Ratios and Statistics

BROOKFIELD CORP

NYSE:BN (3/16/2026, 8:10:18 PM)

After market: 39.4 +0.26 (+0.66%)

39.14

+0.77 (+2.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners60.07%
Inst Owner Change49.2%
Ins Owners10.32%
Ins Owner ChangeN/A
Market Cap95.89B
Revenue(TTM)75.10B
Net Income(TTM)831.00M
Analysts76.84
Price Target55.59 (42.03%)
Short Float %1.06%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 5.98%
Yearly Dividend0.29
Dividend Growth(5Y)-3.57%
DP84.48%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-17
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.61%
Min EPS beat(2)-2.36%
Max EPS beat(2)7.58%
EPS beat(4)3
Avg EPS beat(4)5.79%
Min EPS beat(4)-2.36%
Max EPS beat(4)11.75%
EPS beat(8)6
Avg EPS beat(8)13.32%
EPS beat(12)9
Avg EPS beat(12)-0.52%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1087.77%
Min Revenue beat(2)1057%
Max Revenue beat(2)1118.53%
Revenue beat(4)4
Avg Revenue beat(4)1158.06%
Min Revenue beat(4)1057%
Max Revenue beat(4)1320.03%
Revenue beat(8)8
Avg Revenue beat(8)978.41%
Revenue beat(12)12
Avg Revenue beat(12)661.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.36%
PT rev (3m)4.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.99%
EPS NY rev (1m)1.18%
EPS NY rev (3m)1.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)2.16%
Revenue NY rev (3m)-6.64%
Valuation
Industry RankSector Rank
PE 17.95
Fwd PE 12.91
P/S 1.29
P/FCF N/A
P/OCF 9.69
P/B 2.06
P/tB N/A
EV/EBITDA 11.33
EPS(TTM)2.18
EY5.57%
EPS(NY)3.03
Fwd EY7.74%
FCF(TTM)-4.58
FCFYN/A
OCF(TTM)4.04
OCFY10.32%
SpS30.36
BVpS19.04
TBVpS-15.23
PEG (NY)0.46
PEG (5Y)N/A
Graham Number30.56
Profitability
Industry RankSector Rank
ROA 0.16%
ROE 1.78%
ROCE 4.73%
ROIC 3.3%
ROICexc 3.44%
ROICexgc 4.36%
OM 26.36%
PM (TTM) 1.12%
GM 37.81%
FCFM N/A
ROA(3y)0.17%
ROA(5y)0.38%
ROE(3y)1.84%
ROE(5y)3.62%
ROIC(3y)3.45%
ROIC(5y)3.35%
ROICexc(3y)3.57%
ROICexc(5y)3.48%
ROICexgc(3y)4.42%
ROICexgc(5y)4.29%
ROCE(3y)4.95%
ROCE(5y)4.8%
ROICexgc growth 3Y-0.98%
ROICexgc growth 5Y5.08%
ROICexc growth 3Y-0.39%
ROICexc growth 5Y4.08%
OM growth 3Y17.08%
OM growth 5Y10.73%
PM growth 3Y-9.6%
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-2.91%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Debt/EBITDA 7.26
Cap/Depr 209.1%
Cap/Sales 28.39%
Interest Coverage 250
Cash Conversion 33.32%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.49
Altman-Z 0.34
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.63%
EPS 3Y-14.72%
EPS 5YN/A
EPS Q2Q%-53.96%
EPS Next Y39.04%
EPS Next 2Y32.32%
EPS Next 3Y30.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y-6.8%
Revenue growth 5Y3.66%
Sales Q2Q%3.76%
Revenue Next Year47.63%
Revenue Next 2Y30.64%
Revenue Next 3Y18.44%
Revenue Next 5YN/A
EBIT growth 1Y-12.26%
EBIT growth 3Y9.11%
EBIT growth 5Y14.78%
EBIT Next Year136.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.8%
OCF growth 3YN/A
OCF growth 5YN/A

BROOKFIELD CORP / BN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BROOKFIELD CORP (BN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BN.


What is the valuation status for BN stock?

ChartMill assigns a valuation rating of 4 / 10 to BROOKFIELD CORP (BN). This can be considered as Fairly Valued.


How profitable is BROOKFIELD CORP (BN) stock?

BROOKFIELD CORP (BN) has a profitability rating of 3 / 10.


What are the PE and PB ratios of BROOKFIELD CORP (BN) stock?

The Price/Earnings (PE) ratio for BROOKFIELD CORP (BN) is 17.95 and the Price/Book (PB) ratio is 2.06.


What is the earnings growth outlook for BROOKFIELD CORP?

The Earnings per Share (EPS) of BROOKFIELD CORP (BN) is expected to grow by 39.04% in the next year.